Nasdaq · CIK 0001757499
SHPH Shuttle Pharmaceuticals Holdings, Inc.
Insider trading from SEC Form 4. Last filing Aug 13, 2025.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has 5 SEC Form 4 filings on file from 5 insiders, the latest filed on Aug 13, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Shuttle Pharmaceuticals Holdings, Inc., scored.
Transactions
Every row filed, 6 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Steven M Richards director | AGrant or award Restricted Stock Unitderivative | +29,240 | $0.00 | $0 | 29,240 | Aug 13, 2025 |
| Aug 8, 2025 | Timothy J. Lorber Chief Financial Officer | AGrant or award Restricted Stock Unitderivative | +29,240 | $0.00 | $0 | 29,240 | Aug 12, 2025 |
| Aug 8, 2025 | Oleh Nabyt director | AGrant or award Restricted Stock Unitderivative | +29,240 | $0.00 | $0 | 29,240 | Aug 12, 2025 |
| Aug 8, 2025 | George Scorsis director | AGrant or award Restricted Stock Unitderivative | +29,240 | $0.00 | $0 | 29,240 | Aug 12, 2025 |
| Aug 8, 2025 | Joseph Tung director | AGrant or award Restricted Stock Unitderivative | +29,240 | $0.00 | $0 | 29,240 | Aug 12, 2025 |
| Aug 8, 2025 | Timothy J. Lorber Chief Financial Officer | AGrant or award Restricted Stock Unitderivative | +24,854 | $0.00 | $0 | 24,854 | Aug 12, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Timothy J. LorberChief Financial Officer
- Oleh Nabytdirector
- Steven M Richardsdirector
- George Scorsisdirector
- Joseph Tungdirector
Questions about SHPH
Answered from the filings on this page, as of the latest one.
Are insiders buying SHPH?
No. In the last 90 days no insider at Shuttle Pharmaceuticals Holdings, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SHPH on the open market?
No open-market trade has been scored at Shuttle Pharmaceuticals Holdings, Inc.. The latest Form 4 on file was filed on Aug 13, 2025 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Shuttle Pharmaceuticals Holdings, Inc.?
5 people have filed a Form 4 at Shuttle Pharmaceuticals Holdings, Inc., among them Timothy J. Lorber (Chief Financial Officer), Oleh Nabyt (director), Steven M Richards (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.